Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol Oral Solution PK in Infants
NCT02221674Phase 2Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tapentadol in postoperative pain, sponsored by Grünenthal GmbH. Started Nov 2014; status: terminated.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02221674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221674.